United States · Funded startup

Who invested in Humacyte

4 rounds we have observed, with the 6 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$297Mraised across 4 rounds since 2012, from 4 sources

$22MDebt$50MDebt$150MSeries B$75MRound
Latest round
Round, $75MMar 2018
Biggest round
$150MSeries B · Oct 2015
Investors
6
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2012201320142015201620172018
$22MDebt$50MDebt$150MSeries B$75MRound
First round
Debt, $22M
Apr 2012
Biggest round
$150M
Series B · Oct 2015
Usual gap between rounds
21 months
the median of 3

The rounds

  1. Mar 2018
    Round$75M

    No investor was named in the report.

    Reported by WraltechwireSEC filing: $75M sold, first sale Feb 2018

  2. Oct 2015
    Series B$150M6 new

    From a historical funding record

  3. Jan 2014
    Debt$50M

    No investor was named in the report.

    From a historical funding recordSEC filing: $37M sold, first sale Oct 2007

  4. Apr 2012
    Debt$22M

    No investor was named in the report.

    Reported by sec.govSEC filing: $22M sold, first sale Oct 2007

Founders and team

From Humacyte's own website and the SEC filings it signed: 9 on the team.

  • Jim MercadanteChief Commercial Officer
  • Lisa MolyneuxChief Strategy Officer
  • Dale A. SanderChief Corporate Development Officer ,
  • Carrie S. CoxExecutive Officer, Directori
  • Jeffrey H. LawsonExecutive Officeri
  • Kathleen A. SebeliusChair of the Board
  • Paul A. BoyerExecutive Officeri
  • Theodore D. LithgowExecutive Officeri
  • William H. TenteExecutive Officeri

On the board, as filediBrady W. DouganLaura E. NiklasonMax N. WallaceRobert AndersonRobert S. Langer

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Debt2012Debt2014Series B2015Round2018Access IndustriesBangkok BankPacific Eagle Asset ManagementReignwood GroupBrady DouganGavril Yushvaev

Everyone who backed them

Access IndustriesCorporate VC1round
Bangkok BankGrowth equity1round
Reignwood GroupCompany1round
Brady Douganno record of our own yet1round
Gavril Yushvaevno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 2 firms list Humacyte as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.

Oberland CapitalPrivate creditPer its own site

Quick answers about Humacyte

Who invested in Humacyte?

Humacyte's investors include Access Industries, Bangkok Bank, Pacific Eagle Asset Management, Reignwood Group and Brady Dougan, and 1 more on record.

How much has Humacyte raised?

Humacyte has raised $297M across 4 rounds since 2012.

When did Humacyte last raise?

Humacyte's most recent round was an Undisclosed round of $75M in Mar 2018.

What was Humacyte's biggest round?

Humacyte's largest round on record is $150M (Series B), in Oct 2015.

Who backed Humacyte first?

Humacyte's first round on record, in Oct 2015, was backed by Access Industries, Bangkok Bank and Pacific Eagle Asset Management and 3 others.

What stage is Humacyte at?

Humacyte's latest named round is an Undisclosed round, in Mar 2018.

Where is Humacyte based?

Humacyte is based in the United States.

Companies like Humacyte

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.